CLINICAL_TRIALS
trial_result
· 2019-05-24
Clinical Trial Update: The Role of Vasopressin in the Social Deficits of Autism [Phase 2]
Summary
Phase 2 clinical trial investigating vasopressin for social deficits in autism has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stanford University | Conditions: Autism Spectrum Disorders | Phase 2 | Status: COMPLETED | Results posted: 2019-05-24